Jeffrey Scott Sherman

This profile gathers the share dealings of Jeffrey Scott Sherman across 2 companies, led by Neogenomics Inc and Privia Health Group, Inc. Over a trading history stretching from 5 January 2022 to 21 February 2026, the count stands at 12 filings.

Every open-market trade on record is a purchase: 2 purchases worth €229k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 share grants and 5 option exercises.

On 24 February 2026 came the latest disclosure, an option exercise in Neogenomics Inc. The clock since the last published purchase (6 August 2025) now reads 438 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.